Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barrios

Showing results (331-340 of 7,742) with videos related to

Pageof 775
Sort By:
Frontiers in Chemistry|September 5, 2019
Pushing the Ligand Efficiency Metrics: Relative Group Contribution (RGC) Model as a Helpful Strategy to Promote a Fragment "Rescue" EffectAndrés Felipe Vásquez, Andrés González Barrios
Pharmaceutics|September 6, 2019
PVP-H<sub>2</sub>O<sub>2</sub> Complex as a New Stressor for the Accelerated Oxidation Study of Pharmaceutical SolidsDattatray Modhave, Brenda Barrios, Amrit Paudel
Journal of Inorganic Biochemistry|January 1, 2008
Tuning the Au(I)-mediated inhibition of cathepsin B through ligand substitutionsShamila S Gunatilleke, Amy M Barrios
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 14, 2004
Pigmented conjunctival lesions as initial manifestation of ochronosisPatricia Chévez Barrios, Ramon L Font
Nutritional Neuroscience|August 7, 2008
Naltrexone treatment produces dose-related effects on food and water intake but daily alcohol consumption is not affectedJorge Juárez, Eliana Barrios De Tomasi
Obesity (Silver Spring, Md.)|February 6, 2010
Clinical profile and management of patients with hypertension and chronic ischemic heart disease according to BMIVivencio Barrios, Carlos Escobar, Alberto Calderón
Beilstein Journal of Nanotechnology|July 8, 2017
A top-down approach for fabricating three-dimensional closed hollow nanostructures with permeable thin metal wallsCarlos Angulo Barrios, Víctor Canalejas-Tejero
Fundamental & Clinical Pharmacology|March 21, 2009
Importance of medication adherence from the ONTARGET and TRANSCEND points of viewVivencio Barrios, Carlos Escobar, Rocio Echarri
International Journal of Clinical Practice|June 4, 2009
Chronic kidney disease: the forgotten cardiovascular risk factorV Barrios, C Escobar, R Echarri
Expert Review of Cardiovascular Therapy|September 18, 2007
Candesartan: from left ventricular hypertrophy to heart failure, a global approachVivencio Barrios, Carlos Escobar, Alberto Calderon
Pageof 775

Showing results (331-340 of 7,742) with videos related to

Sort By:
Pageof 775
Frontiers in Chemistry|September 5, 2019
Pushing the Ligand Efficiency Metrics: Relative Group Contribution (RGC) Model as a Helpful Strategy to Promote a Fragment "Rescue" EffectAndrés Felipe Vásquez, Andrés González Barrios
Pharmaceutics|September 6, 2019
PVP-H<sub>2</sub>O<sub>2</sub> Complex as a New Stressor for the Accelerated Oxidation Study of Pharmaceutical SolidsDattatray Modhave, Brenda Barrios, Amrit Paudel
Journal of Inorganic Biochemistry|January 1, 2008
Tuning the Au(I)-mediated inhibition of cathepsin B through ligand substitutionsShamila S Gunatilleke, Amy M Barrios
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 14, 2004
Pigmented conjunctival lesions as initial manifestation of ochronosisPatricia Chévez Barrios, Ramon L Font
Nutritional Neuroscience|August 7, 2008
Naltrexone treatment produces dose-related effects on food and water intake but daily alcohol consumption is not affectedJorge Juárez, Eliana Barrios De Tomasi
Obesity (Silver Spring, Md.)|February 6, 2010
Clinical profile and management of patients with hypertension and chronic ischemic heart disease according to BMIVivencio Barrios, Carlos Escobar, Alberto Calderón
Beilstein Journal of Nanotechnology|July 8, 2017
A top-down approach for fabricating three-dimensional closed hollow nanostructures with permeable thin metal wallsCarlos Angulo Barrios, Víctor Canalejas-Tejero
Fundamental & Clinical Pharmacology|March 21, 2009
Importance of medication adherence from the ONTARGET and TRANSCEND points of viewVivencio Barrios, Carlos Escobar, Rocio Echarri
International Journal of Clinical Practice|June 4, 2009
Chronic kidney disease: the forgotten cardiovascular risk factorV Barrios, C Escobar, R Echarri
Expert Review of Cardiovascular Therapy|September 18, 2007
Candesartan: from left ventricular hypertrophy to heart failure, a global approachVivencio Barrios, Carlos Escobar, Alberto Calderon
Pageof 775